NCT06906341 2025-10-22Relacorilant in Combination With Different Treatment Regimens in Patients With Gynecological CancersCorcept TherapeuticsPhase 2 Recruiting270 enrolled
NCT04519151 2023-06-08Pembrolizumab and Lenvatinib for Platinum- Sensitive Recurrent Ovarian CancerSheba Medical CenterPhase 2 Recruiting24 enrolled